Oncology Corporate Profile
Neon Therapeutics is an immuno-oncology company focused on developing novel therapeutics leveraging neoantigen biology to treat cancer. A neoantigen-based product engine will allow Neon to develop further treatment modalities including next-generation vaccines and T cell therapies targeting both personalized as well as shared neoantigens.
|Brand / Product||Class||Area of Study||Phase||Partnership|
|NEO-PV-01 (+ nivolumab)||neoantigen vaccine||Bladder cancer||I||Bristol Myers-Squibb|
|NEO-PV-01 (+ nivolumab)||neoantigen vaccine||Melanoma||I|
|NEO-PV-01 (+ APX005M)||neoantigen vaccine||Melanoma||I||Apexigen|
|NEO-PV-01 (+ nivolumab)||neoantigen vaccine||Non Small Cell Lung Cancer (NSCLC)||I|
View additional information on product candidates here »